Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$21.47
0.472.24%
At close: -
$21.40
-0.07-0.33%
After Hours: Jan 3, 6:00 PM EDT
Comments
Loading...
Overview Rating
Speculative
Genmab (NASDAQ:GMAB) Stock Quotes, Forecast and News Summary
Genmab Stock (NASDAQ: GMAB) stock price, news, charts, stock research, profile.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Genmab (GMAB) stock?
You can purchase shares of Genmab (NASDAQ:GMAB) through any online brokerage.
Who are Genmab (GMAB) competitors?
Other companies in Genmab’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
What is the forecast, or price target, for Genmab (GMAB) stock?
Genmab has a consensus price target of $40.56.
What is the current price for Genmab (GMAB)?
The stock price for Genmab (NASDAQ: GMAB) is $21.4 last updated January 3, 2025 at 6:00 PM EST.
Does Genmab (GMAB) pay a dividend?
There are no upcoming dividends for Genmab.
When is Genmab (NASDAQ:GMAB) reporting earnings?
Genmab’s Q4 earnings are confirmed for Wednesday, February 12, 2025.
Is Genmab (GMAB) going to split?
There is no upcoming split for Genmab.
What sector and industry does Genmab (GMAB) operate in?
Genmab is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.